在阴茎癌中辅助放射治疗的结果
Gerim Prasai1, David K Simson2, Sauharda Lohani3
1Department of Radiation Oncology, Kathmandu Cancer Center, Kathmandu, Nepal.
Advances in radiation oncology
|February 20, 2026
概括
阴茎癌的辅助放射治疗 (RT) 显示了低于最佳的生存结果和高的复发率. 需要改进治疗策略,才能在阴茎癌患者中获得更好的结果.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 尿道瘤学 尿道瘤学
背景情况:
- 阴茎癌,特别是状细胞癌,带来了重大的治疗挑战.
- 辅助放射治疗 (RT) 是阴茎癌手术后的常见方式.
- 在辅助RT后的长期结果和复发模式需要进一步调查.
研究的目的:
- 评估阴茎癌患者辅助放射治疗 (RT) 的长期瘤结果.
- 评估与辅助RT相关的生存率,复发模式和毒性.
- 确定在阴茎癌管理方面需要改进的领域.
主要方法:
- 对30名阴茎癌患者进行了回顾性队列研究,这些患者接受了手术和辅助RT (有或没有化疗).
- 卡普兰-梅尔生存分析方法 (总体生存率[OS]和无复发生存率[RFS]).
- 考克斯比例危险回归用于临床变量和结果的单变量分析.
主要成果:
- 随访时间中位数为84个月;中位数的生存期为77.2个月;5年的生存期为52%.
- 五年无复发生存率 (RFS) 为66%,其中8例复发中的6例是局部区域性的.
- 辅助RT一般耐受良好,淋巴是最常见的副作用.
结论:
- 对阴茎癌的辅助性RT与低于最佳的长期存活率和高位区域复发率有关.
- 目前的治疗策略可能不足以防止阴茎癌复发.
- 需要进一步的研究来开发更有效的阴茎癌治疗方案.
更多相关视频
09:49Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Published on: December 28, 2021
02:21Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
Published on: March 15, 2024
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...